Abstract
Red cell galactose 1-phosphate (Gal-1-P) concentrations and urinary galactitol excretion have been suggested as biochemical indices of dietary compliance in classical transferase-deficient galactosaemia. We report our experience of measuring both in 32 patients over 0–10.9 years (median 3.45). A total of 438 blood specimens for Gal-1-P and 383 urine specimens for galactitol assay were received; 317 pairs of specimens were collected at the same time. Concentrations of both analytes fell rapidly over the first 2–3 months following dietary intervention, to mean (geometric SD) levels of 225 (1.60) μmol/L red cells for Gal-1-P and 388 (1.19) μmol/mmol creatinine for galactitol. Concentrations then fell exponentially over the next 7–8 years, with times to half-disappearance of 6.3 years for Gal-1-P and 6.4 years for galactitol, to levels of 104 (1.58) and 193 (1.36) respectively in patients aged over 10 years. Concentrations of both analytes were independent of the presence of the common Q188R mutation. Mean intra- and inter-individual coefficients of variation (CV) across the range of values studied were 36% and 61% for Gal-1-P, and 37% and 42% for galactitol. Analytical CVs were 3.6% for Gal-1-P and 5.5% for galactitol, indicating that the major source of variability is biological. The correlation coefficient between Gal-1-P and galactitol in paired samples overall was 0.33; the regression equation being [Galactitol] = 0.84[Gal-1-P]+176. Serial measurements of both Gal-1-P and galactitol may be valuable in monitoring galactosaemia, but high intra-individual biological variability limits their usefulness. Standardization of sample collection times may improve this. Further work is needed to assess the predictive values of both analytes for long-term outcome.
Similar content being viewed by others
REFERENCES
Beigi B, OÏKeefe M, Bowell R, Naughten E, Badawi N, Lanigan B (1993) Ophthalmic findings in classical galactosaemia-prospective study. Br J Ophthalmol 77: 162-164.
Berry GT, Palmieri M, Gross KC, et al (1993) The effect of dietary fruits and vegetables on urinary galactitol excretion in galactose-1-phosphate uridyltransferase deficiency. J Inher Metab Dis 16: 91-100.
Berry GT, Nissim I, Lin Z, Mazur AT, Gibson JB, Segal S (1995) Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia. Lancet 346: 1073-1074.
Berry GT, Williamson JR, Wehrli S, et al (1997) Galactonate pathway in normal and GALTde ficient erythrocytes: a new target for aldose reductase inhibitors. J Inher Metab Dis 20 (supplement 1): 86.
Bland JM, Altman DG (1996a) Measurement error proportional to the mean. Br Med J 313: 106.
Bland JM, Altman DG (1996b) Measurement error. Br Med J 313: 744.
Bonham JR, Allen J, Chapman C (1994) Increased urinary transferrin excretion in galactosaemia: a possible indicator of control. Abstracts of the 32nd Annual Symposium of the Society for the Study of Inborn Errors of Metabolism, Edinburgh, UK: SSIEM, P136.
Cotlove E, Harris EK, Williams GZ (1970) Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. III. Physiological and medical implications. Clin Chem 16: 1028-1032.
Dobbie JA, Holton JB (1986) A modified method for the estimation of galactose-1-phosphate. Ann Clin Biochem 3: 352-358.
Donnell GN, Bergren WR, Perry G, Koch R (1963) Galactose-1-phosphate in galactosemia. Pediatrics 31: 802-810.
Egan TJ, Wells WW (1966) Alternative metabolic pathway in galactosemia. Am J Dis Child 111: 400-405.
Fraser CG, Harris EK (1989) Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin L ab Sci 27: 409-437
Fraser CG, Petersen PH, Libeer J-C, Ricos C (1997) Proposals for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 34: 8-12.
Gregory J, Foster K, Tyler H, Wiseman M (1990) The Dietary and Nutritional Survey of British Adults. London: HMSO.
Harris EK (1979) Statistical principles underlying analytic goal-setting in clinical medicine. Am J Clin Pathol 72: 374-382.
Harris EK (1981) Statistical aspects of reference values in clinical pathology. Prog Clin Pathol 8: 45-66.
Honeyman MM, Green A, Holton JB, Leonard JV (1993) Galactosaemia: results of the British Paediatric Surveillance Unit study, 1988-90. Arch Dis Child 69: 339-341.
Kalderon B, Dixon R, Rajogopalan B, et al (1992) A study of galactose intolerance in human and rat liver in vivo by 31P magnetic resonance spectroscopy. Pediatr Res 32: 39-44.
Murphy D, Pennock CA (1972) Gas chromatographic measurement of blood and urine glucose and other monosaccharides. Clin Chim Acta 42: 67.
Ornstein KS, McGuire EJ, Berry GT, Roth S, Segal S (1992) Abnormal galactosylation of complex carbohydrates in cultured fibroblasts from patients with galactose-1-phosphate uridyltransferase deficiency. Pediatr Res 31: 508-511.
Pesce MA, Bodourian SH (1982) Clinical significance of plasma galactose and erythrocyte galactose-1-phosphate measurements in transferase-deficient galactosemia and in individuals with below-normal transferase activity. Clin Chem 28: 301-305.
Prestoz LLC, Couto AS, Shin YS, Petry KG (1997) Altered follicle stimulating hormone isoforms in female galactosaemic patients. Eur J Pediatr 156: 116-120.
Schwarz V (1960) The value of galactose phosphate determinations in the treatment of galactosaemia. Arch Dis Child 35: 428-432.
Segal S, Berry GT (1995) Disorders of galactose metabolism. In Scriver C, Beaudet A, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th edn. New York: McGraw-Hill, 967-1000.
Waggoner DD, Buist NRM, Donnell GN (1990) Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inher Metab Dis 13: 802-818.
Weinstein AN, Segal S (1968) The metabolic fate of 1-14C galactitol in mammalian tissue. Biochim Biophys Acta 156: 9-16.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hutcheson, A.C.J., Murdoch-Davis, C., Green, A. et al. Biochemical monitoring of treatment for galactosaemia: Biological variability in metabolite concentrations. J Inherit Metab Dis 22, 139–148 (1999). https://doi.org/10.1023/A:1005493701913
Issue Date:
DOI: https://doi.org/10.1023/A:1005493701913